About this trial
Clinical trials, specifically focused on TBI, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Eligibility criteria
Qualifiers
Ability to understand and the willingness to sign a written informed consent document
Participant must be 18 years of age or older
Confirmed diagnosis of TBI
Disqualifiers
Enrolled in another research study
Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
Inability to provide written informed consent
Trial design
Treatments tested in this trial
- Not listed